Trial intelligence / Profile preview

High-dose cisatracurium vs rocuronium for rapid sequence intubation

TCTR20210824007Phase 2Completed

Sponsor
Faculty of Medicine Ramathibodi Hospital, Mahidol University
Start
Aug 2021
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of cisatracurium, rocuronium in None, sponsored by Faculty of Medicine Ramathibodi Hospital, Mahidol University. Started Aug 2021; status: completed.

02

Drugs

cisatracuriumrocuronium

Beyond the preview

Go deeper on TCTR20210824007.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20210824007.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call